Applied Molecular Transport to Present at BofA Securities 2021 Health Care Conference

Rhea-AI Summary

Applied Molecular Transport Inc. (Nasdaq: AMTI) announced that CEO Tahir Mahmood, Ph.D., will participate in a fireside chat at the BofA Securities 2021 Health Care Conference on May 12, 2021, at 2:00 p.m. ET. A live webcast will be available on the company's Events page, with an archived replay accessible for 30 days post-event. The company specializes in developing novel oral biologic products targeting autoimmune and inflammatory diseases using its proprietary technology to facilitate efficient transport across the intestinal barrier.

SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 2:00 p.m. ET.

A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. An archived replay will be available for 30 days following the event.

About Applied Molecular Transport Inc.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelial (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease.

AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com.

Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com

Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

FAQ

What is AMTI's participation in the BofA Securities 2021 Health Care Conference?

Applied Molecular Transport Inc. (AMTI) will have CEO Tahir Mahmood participate in a fireside chat during the conference on May 12, 2021.

When will the AMTI fireside chat take place?

The fireside chat is scheduled for May 12, 2021, at 2:00 p.m. ET.

How can I watch the AMTI fireside chat?

The chat will be broadcast live via the Events page on the Applied Molecular Transport website.

Will there be a replay of the AMTI fireside chat?

Yes, an archived replay will be available for 30 days following the event.

What does Applied Molecular Transport do?

Applied Molecular Transport is a clinical-stage biopharmaceutical company focusing on developing oral biologic product candidates for various diseases.